4.4 Article

Siglec-14 Enhances NLRP3-Inflammasome Activation in Macrophages

Journal

JOURNAL OF INNATE IMMUNITY
Volume 12, Issue 4, Pages 333-343

Publisher

KARGER
DOI: 10.1159/000504323

Keywords

Siglec; Interleukin-1 beta; Caspase-1; Inflammasome; Macrophages; Innate immunity; Vimentin

Categories

Funding

  1. NIH/NHLBI Program of Excellence in Glycosciences [P01 HL107150]
  2. NIH/NHLBI grant [HL125352]
  3. UC President's Postdoctoral Fellowship
  4. San Diego IRACDA Fellowship [NIH/NIGMS K12 GM068524]

Ask authors/readers for more resources

Pathogenic microorganisms are sensed by the inflammasome, resulting in the release of the pro-immune and proinflammatory cytokine interleukin-1 beta (IL-1 beta). In humans, the paired sialic acid-binding Ig-like lectin receptors Siglec-5 (inhibitory) and Siglec-14 (activating) have been shown to have reciprocal roles in regulating macrophage immune responses, but their interaction with IL-1 beta signaling and the inflammasome has not been characterized. Here we show that in response to known inflammasome activators (ATP, nigericin) or the sialic acid-expressing human bacterial pathogen group BStreptococcus(GBS), the presence of Siglec-14 enhances, whereas Siglec-5 reduces, inflammasome activation and macrophage IL-1 beta release. Human THP-1 macrophages stably transfected with Siglec-14 exhibited increased caspase-1 activation, IL-1 beta release and pyroptosis after GBS infection, in a manner blocked by a specific inhibitor of nucleotide-binding domain leucine-rich repeat protein 3 (NLRP3), a protein involved in inflammasome assembly. Another leading pathogen,Streptococcus pneumoniae, lacks sialic acid but rather prominently expresses a sialidase, which cleaves sialic acid from macrophages, eliminatingcis- interactions with the lectin receptor, thus attenuating Siglec-14 induced IL-1 beta secretion. Vimentin, a cytoskeletal protein released during macrophage inflammatory activation is known to induce the inflammasome. We found that vimentin has increased interaction with Siglec-14 compared to Siglec-5, and this interaction heightened IL-1 beta production by Siglec-14-expressing cells. Siglec-14 is absent from some humans because of aSIGLEC5/14fusion polymorphism, and we found increased IL-1 beta expression in primary macrophages fromSIGLEC14(+/+) individuals compared to those with theSIGLEC14(-/+) andSIGLEC14(-/-) genotypes. Collectively, our results identify a new immunoregulatory role of Siglec-14 as a positive regulator of NLRP3 inflammasome activation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available